Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigeyuki Tahara

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
No Shinkei Geka. Neurological Surgery|April 27, 2026
[Clinically Non-Functioning Pituitary Adenoma/Pituitary Neuroendocrine Tumor (PitNET)]Shigeyuki Tahara
No Shinkei Geka. Neurological Surgery|June 7, 2022
[Points and Pitfalls of Deep Dural Suture]Koji Suzuki, Shigeyuki Tahara
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 12, 2011
[Present conditions and the prospects of the clinical studies of hypothalamus, and the pituitary tumor]Shigeyuki Tahara, Akira Teramoto
No Shinkei Geka. Neurological Surgery|July 25, 2023
[Epidemiology, Genetics and Pathogenesis of Pituitary Neuroendocrine Tumors]Koji Suzuki, Shigeyuki Tahara
Neurology and Therapy|October 24, 2023
Recognition and Practice of Hypopituitarism After Traumatic Brain Injury and Subarachnoid Hemorrhage in Japan: A SurveyShigeyuki Tahara, Fumio Otsuka, Takaaki Endo
No to Shinkei = Brain and Nerve|July 30, 2003
[Endoscopic pituitary tumor surgery]Shigeyuki Tahara, Takayuki Kitamura, Akira Teramoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 6, 2005
[Pituitary adenoma]Shigeyuki Tahara, Naoko Sanno, Akira Teramoto
Neurologia Medico-Chirurgica|May 10, 2021
Bacterial Flora in the Sphenoid Sinus Changes with Perioperative Prophylactic Antibiotic AdministrationEiichi Baba, Yujiro Hattori, Shigeyuki Tahara, et al.
Neurologia Medico-Chirurgica|December 3, 2014
Endoscopic endonasal skull base surgery: advantages, limitations, and our techniques to overcome cerebrospinal fluid leakage: technical noteYudo Ishii, Shigeyuki Tahara, Akira Teramoto, et al.
Endocrine Journal|June 9, 2017
Efficacy and safety of long-acting pasireotide in Japanese patients with acromegaly or pituitary gigantism: results from a multicenter, open-label, randomized, phase 2 studyShigeyuki Tahara, Mami Murakami, Tomomi Kaneko, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
No Shinkei Geka. Neurological Surgery|April 27, 2026
[Clinically Non-Functioning Pituitary Adenoma/Pituitary Neuroendocrine Tumor (PitNET)]Shigeyuki Tahara
No Shinkei Geka. Neurological Surgery|June 7, 2022
[Points and Pitfalls of Deep Dural Suture]Koji Suzuki, Shigeyuki Tahara
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 12, 2011
[Present conditions and the prospects of the clinical studies of hypothalamus, and the pituitary tumor]Shigeyuki Tahara, Akira Teramoto
No Shinkei Geka. Neurological Surgery|July 25, 2023
[Epidemiology, Genetics and Pathogenesis of Pituitary Neuroendocrine Tumors]Koji Suzuki, Shigeyuki Tahara
Neurology and Therapy|October 24, 2023
Recognition and Practice of Hypopituitarism After Traumatic Brain Injury and Subarachnoid Hemorrhage in Japan: A SurveyShigeyuki Tahara, Fumio Otsuka, Takaaki Endo
No to Shinkei = Brain and Nerve|July 30, 2003
[Endoscopic pituitary tumor surgery]Shigeyuki Tahara, Takayuki Kitamura, Akira Teramoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 6, 2005
[Pituitary adenoma]Shigeyuki Tahara, Naoko Sanno, Akira Teramoto
Neurologia Medico-Chirurgica|May 10, 2021
Bacterial Flora in the Sphenoid Sinus Changes with Perioperative Prophylactic Antibiotic AdministrationEiichi Baba, Yujiro Hattori, Shigeyuki Tahara, et al.
Neurologia Medico-Chirurgica|December 3, 2014
Endoscopic endonasal skull base surgery: advantages, limitations, and our techniques to overcome cerebrospinal fluid leakage: technical noteYudo Ishii, Shigeyuki Tahara, Akira Teramoto, et al.
Endocrine Journal|June 9, 2017
Efficacy and safety of long-acting pasireotide in Japanese patients with acromegaly or pituitary gigantism: results from a multicenter, open-label, randomized, phase 2 studyShigeyuki Tahara, Mami Murakami, Tomomi Kaneko, et al.
Pageof 9